Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Endocrine disruptors

The burden of endocrine-disrupting chemicals in the USA

Endocrine-disrupting chemicals (EDCs) can contribute to the development of certain disorders and are known to have a high health-care burden in some countries. A new analysis has revealed the substantial impact of EDCs on health and associated costs in the USA.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type



Prices may be subject to local taxes which are calculated during checkout


  1. Attina, T. M. et al. Exposure to endocrine-disrupting chemicals in the USA: a population-based disease burden and cost analysis. Lancet Diabetes Endocrinol. (2016).

  2. Trasande, L. et al. Estimating burden and disease costs of exposure to endocrine disrupting chemicals in the European Union. J. Clin. Endocrinol. Metab. 100, 1245–1255 (2015).

    Article  CAS  Google Scholar 

  3. Skakkebaek, N. E. et al. Male reproductive disorders and fertility trends: influences of environment and genetic susceptibility. Physiol. Rev. 96, 55–97 (2016).

    Article  CAS  Google Scholar 

  4. Bergman, A., Heindel, J. J., Jobling, S., Kidd, K. A. & Zoeller, R. T. (eds) State of the Science of Endocrine Disrupting Chemicals — 2012 (WHO–UNEP, 2013).

    Google Scholar 

  5. Slama, R. et al. Scientific issues relevant to setting regulatory criteria to identify endocrine-disrupting substances in the European Union. Environ. Health Perspect. 124, 1497–1503 (2016).

    Article  Google Scholar 

  6. Jones, G., Garthwaite, D., Wynne, S. & Twining, G. Agronomic and economic impact assessment for possible human health and ecotoxicology criteria for endocrine disrupting chemicals. Report to Chemicals Regulation Directorate. FERA (2013).

  7. Kristensen, D. et al. Analgesics use — prevalence, biomonitoring and endocrine and reproductive effects. Nat. Rev. Endocrinol. 12, 381–393 (2016).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to Andreas Kortenkamp.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kortenkamp, A. The burden of endocrine-disrupting chemicals in the USA. Nat Rev Endocrinol 13, 6–7 (2017).

Download citation

  • Published:

  • Issue Date:

  • DOI:

This article is cited by


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing